Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Postoperative complications like seroma formation and wound site infection readily occur following completion axillary lymph node dissection (ALND) for malignant melanoma. We analyzed the impact of time-to-drain removal and drainage volume on seroma formation after ALND.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| daily drainage volume during hospitalization | The daily drainage amount durin hospital stay | through study completion, an average of 1 year |
| total drainage volume during hospitalization | The total drainage amount during hospital stay | through study completion, an average of 1 year |
| time-to-drain removal | The timepoint when the drain was removed | through study completion, an average of 1 year |
| evacuation of seroma after drain removal | If evacuation of seroma after drain removal was needed | through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| demographic data - age | age | through study completion, an average of 1 year |
| demographic data - sex | sex | through study completion, an average of 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Included patients had a histologically confirmed malignant melanoma (MM), underwent axillary lymph node dissection (level I-III) and had daily drainage volume records over a two-week period. Prior data collection we obtained ethical approval (institutional review board #25-438 ex 12/13). Data collection and analysis were performed in accordance with the rules set by the Declaration of Helsinki.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David B Lumenta, MD, Prof | Medical University of Graz | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Graz | Graz | Styria | 8036 | Austria |
Not provided
| ID | Term |
|---|---|
| D008545 | Melanoma |
| ID | Term |
|---|---|
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
Not provided
Not provided
Not provided
| demographic data - BMI | body mass index (BMI) | through study completion, an average of 1 year |
| demographic data - smoking | smoking | through study completion, an average of 1 year |
| demographic data - Diabetes mellitus | diabetes mellitus | through study completion, an average of 1 year |
| demographic data - allergies | allergies | through study completion, an average of 1 year |
| intraoperative parameters | surgical procedure time | through study completion, an average of 1 year |
| intraoperative parameters - site | site | through study completion, an average of 1 year |
| Amount of histologically analyzed lymph nodes | The amount lymph nodes found at histological analysis | through study completion, an average of 1 year |
| Surgical complications | graded by the Clavien-Dindo-classification ( 1:normal postoperative cause without need of pharmacological treatment ; 2: pharmacological treatment ; 3: surgical, endoscooic or radiological treatment; 4: live-threating complications; 5: Death | through study completion, an average of 1 year |
| D009369 | Neoplasms |
| D009380 | Neoplasms, Nerve Tissue |
| D018326 | Nevi and Melanomas |
| D012878 | Skin Neoplasms |
| D009371 | Neoplasms by Site |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |